Presseinformationen weltweit an Journalisten und Leser verbreiten
VSY Biotechnology, leading ophthalmic and orthopedic medical device and biotechnology company, announces the appointment of Nagihan ŞENGÜL KARPUZ to the company’s Board of Directors. Nagihan Şengül Karpuz has been appointed Board Member of VSY Biotechnology. She began her carrier at Mehr
VSY Biotechnology announces the launch of the Enova® C Haptic Model IOL. Enova® is the first and only 100% Glistening-Free, Dry-Packed hydrophobic acrylic IOL. Moreover, no warming or special conditioning is required before surgery! VSY Biotechnology Launches Enova® 100% Glistening-Free Hydrophobic Mehr
VSY Biotechnology, leading ophthalmic and orthopedic medical device and biotechnology company, announces the appointment of seasoned executive leader Can Ongen to the company’s Board of Directors. In this role, Can Ongen will also lead VSY Biotechnology’s sales and marketing activities Mehr
VSY Biotechnology GmbH, an innovation-driven company with its progressive R&D activities in ophthalmology, visco supplementation in orthopedy and medical esthetics, announced today an agreement with WAKAMOTO PHARMACEUTICAL CO., LTD. (hereinafter refer to "WAKAMOTO PHARMACEUTICAL") to provide new treatments for cataract Mehr
VSY Biotechnology provides the best vision to people worldwide and supplies the best technology to ophthalmologists. The company’s Pre-loaded IOL System Patent has been granted by the Japan Patent Office. VSY Biotechnology’s innovations are indeed for the comfort of everyone Mehr
VSY Biotechnology Introduces Protectalon DUO Kit, demonstrating commitment to Ophthalmic Surgery! Eye Care Professionals meet their OVD needs at different stages of cataract surgery with a single kit. It is available now for safe, fast and smooth surgery! SPECIFICATIONS: Dual Pack Mehr
VSY Biotechnology GmbH, an innovation-driven company with progressive R&D activities in ophthalmology, has announced the winners of the 2020 Ophthalmology Star Awards. This year’s “Ophthalmology Star Award” is dedicated to Dr. Li Wenliang, an an ophthalmologist who was the first Mehr
VSY Biotechnology announced that it is moving its headquarters from the Netherlands to Germany. VSY Biotechnology GmbH will be the company’s new headquarters. VSY Biotechnology commenced operations in the late 90s. Since then, the company has achieved several milestones Mehr
As part of the Ophthalmology Star Awards (OSA), articles by ophthalmologists published in English since January 2019 are being evaluated by an international jury. Ophthalmologists can apply for the contest until July 15, 2020, from the OSA page (https://www.vsybiotechnology.com/…) on Mehr
VSY Biotechnology Research Center has developed a strong R&D program in various areas of biotechnology and is now proud to announce its latest achievement: TR-C 19, a drug to treat COVID-19. At VSY Biotechnology GmbH, we are very excited to announce that a new drug, Mehr